Success Stories: Thanks to Our Team Work, NIW Confirmation Assured for a Researcher in Biomedical Science Hailing from Nepal, Despite RFE
Client’s Testimonial:
“Thank you so much for the successful I-140!!!”
On October 6th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Researcher
Country of Origin: Nepal
State of Residence at the Time of Filing: Missouri
Approval Notice Date: October 6th, 2022
Processing Time: 10 months, 27 days
Case Summary:
The I140-NIW or National Interest Waiver is a kind of nonimmigrant visa designed for those individuals whose work is of benefit to the U.S. Such individuals who get an NIW approval, are allowed to continue their work in the U.S. without a permanent job offer or labor certification. The following regulatory criteria play an important role in the approval process are:
- Evidence of original scientific, scholarly, artistic, or business-related contributions of major significance
- Evidence of authorship of scholarly articles in the field, in professional or major trade publications or other major media
- Evidence of membership in associations in the field that demand outstanding achievement
- As an expert in the field of biomedical science, her proposed endeavor is to continue her research on analyzing the genetic networks underlying Alzheimer’s disease in order to develop early diagnostic procedures and effective treatments.
- Her research advancing her proposed endeavor is of great importance because it aids in revealing the underlying genetic factors in Alzheimer’s disease, improving methods for early diagnosis, and supporting the development of new treatments.
- In addition, her proposed endeavor has broad implications for the United States. Her research on Alzheimer’s disease directly contributes to diagnosing and treating a significant health issue in the United States.
- Her research has in fact been supported with funding from two branches of the National Institutes of Health (NIH) – the National Institute on Aging and the National Institute of Neurological Disorders and Stroke – as well as the NIH itself. Furthermore, her study has received funding from the Alzheimer’s Association, Mayo Alzheimer’s Disease Research Center, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke.
- Her high status in the field is further demonstrated by her membership with a prestigious institution working on neurology here in the U.S.
- Her research has resulted in 4 peer-reviewed journal articles and 1 book chapter which have been cited a total of 75 times according to Google Scholar.
- She has been pursuing research directly related to her proposed endeavor of analyzing the genetic networks underlying Alzheimer’s disease and other neurodegenerative diseases for 7 years now, giving her the necessary expertise in the field.